Rosemary for Anti-Inflammatory

Research suggests that rosemary and its key bioactive compounds — particularly carnosic acid, carnosol, and rosmarinic acid — demonstrate meaningful anti-inflammatory activity across a consistent body of preclinical evidence. Studies indicate these compounds work through multiple cellular signaling pathways, including NF-κB, MAPK, and Nrf2, to reduce the production of pro-inflammatory molecules such as TNF-α, IL-1, and IL-6, with supporting findings from reviews covering topical, neurological, and general pharmacological applications. The available evidence comes primarily from in vitro experiments, animal studies, and narrative or systematic reviews rather than randomized controlled trials in humans, which is an important limitation when interpreting how these findings might translate to real-world use. One review noted mixed conclusions about the broader therapeutic potential of rosemary essential oil specifically, and a 2025 safety-focused review cautioned that high or prolonged doses may carry risks, underscoring that more rigorous human clinical research is needed before strong conclusions can be drawn.